Boxidine

This classification denotes an anti-lipidemic agent with the molecular formula C19H20F3NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8MJ40K4117, chemically known as pyrrolidine, 1-(2-((4-(trifluoromethyl)(1,1-biphenyl)-4-yl)oxy)ethyl)- but generally known as boxidine, which bears US NIH Compound Identifier 31742. Boxidine most often comes in base and hydrochloride forms. European Medicines Agency schedules Boxidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05879MIG. The term BOXIDINE is an International Non-Proprietary Name. BOXIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule boxidine under HS 29339990 and SITC 51577. As of Q4 2014, BOXIDINE remains the US FDA Preferred Term for this commodity. Boxidine bears US NLM identifiers UMLS ID C0663338 and NCI Concept Code C91025. SMILES: FC(F)(F)c1ccc(c2ccc(OCCN3CCCC3)cc2)cc1.